Overview

Safety and Pharmacokinetic Study of Intravenous Ibuprofen in Pediatric Patients

Status:
Completed
Trial end date:
2019-07-02
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate the pharmacokinetic profile of a single dose of intravenous ibuprofen administered over approximately ten (10) minutes.
Phase:
Phase 4
Details
Lead Sponsor:
Cumberland Pharmaceuticals
Treatments:
Ibuprofen